Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors
Stopped Delayed recruitment mainly due to a screening to inclusion rate much lower than expected. Due to the delayed recruitment IMP reached the end of its shelf life.
Conditions
- Hypogonadism
- Pre-frail Seniors
Interventions
- DRUG: Testosterone
- DRUG: Colecalciferol
- DRUG: Placebo drink solution
- DRUG: Placebo transdermal gel
Sponsor
University of Zurich
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]